Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon.
about
Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapyQuantification of macrophage cell surface molecules in rheumatoid arthritisTreatment of juvenile idiopathic arthritis: a revolution in careMorphological evidence that activated polymorphs circulate in the peripheral blood of patients with rheumatoid arthritis.Determination of cytokines in synovial fluids: correlation with diagnosis and histomorphological characteristics of synovial tissue.Cerebrospinal fluid concentrations of interleukin-1 beta, tumour necrosis factor-alpha, and interferon gamma in bacterial meningitisEffect of gold sodium thiomalate and its thiomalate component on the in vitro expression of endothelial cell adhesion molecules.Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein.Diverse expression of selected cytokines and proteinases in synovial fluid obtained from osteoarthritic and healthy human knee joints.15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in ratsNew insights into Lyme disease.TNF receptor gene therapy results in suppression of IgG2a anticollagen antibody in collagen induced arthritis.Biodistribution of etanercept to tissues and sites of inflammation in arthritic rats.Cytokine regulation of human lung fibroblast hyaluronan (hyaluronic acid) production. Evidence for cytokine-regulated hyaluronan (hyaluronic acid) degradation and human lung fibroblast-derived hyaluronidase.Studies on early events of Borrelia burgdorferi-induced cytokine production in immunodeficient SCID mice by using a tissue chamber model for acute inflammationRecombinant gamma interferon causes neutrophil migration mediated by the release of a macrophage neutrophil chemotactic factorTransforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype.Carrageenan-induced acute inflammation in the mouse air pouch synovial model. Role of tumour necrosis factor.In vitro and in vivo induction of tumor necrosis factor alpha by Borrelia burgdorferi.Endotoxin tolerance: independent regulation of interleukin-1 and tumor necrosis factor expression.Tumor necrosis factor alpha, citrullination, and peptidylarginine deiminase 4 in lung and joint inflammation.Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences.Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice.Tyrosine kinases in rheumatoid arthritis.Activation of human monocytes by Streptococcus mutans serotype f polysaccharide: immunoglobulin G Fc receptor expression and tumor necrosis factor and interleukin-1 production.Neutrophils isolated from the synovial fluid of patients with rheumatoid arthritis: priming and activation in vivoActivation of the neutrophil myeloperoxidase-H2O2 system by synovial fluid isolated from patients with rheumatoid arthritis.Transcriptional modulation of cartilage-specific collagen gene expression by interferon gamma and tumour necrosis factor alpha in cultured human chondrocytes.Pharmacological analysis for mechanisms of GPI-80 release from tumour necrosis factor-alpha-stimulated human neutrophils.Activation of neutrophil reactive-oxidant production by synovial fluid from patients with inflammatory joint disease. Soluble and insoluble immunoglobulin aggregates activate different pathways in primed and unprimed cells.Heterogeneity of the Type I Interferon Signature in Rheumatoid Arthritis: A Potential Limitation for Its Use As a Clinical Biomarker.Minimal physiologically-based pharmacokinetic (mPBPK) model for a monoclonal antibody against interleukin-6 in mice with collagen-induced arthritis.
P2860
Q24601075-A4C90ABC-B8E4-464D-9918-9AF27229AC90Q24678305-1A888AAB-C1F1-4FE5-89BD-AC5D7DD14D4DQ26849497-3F87726A-9218-40B5-AA9C-BDECCF158754Q33564177-CEC19672-2191-4244-8592-1CEB56A865C5Q33564673-407B2AFB-2685-470C-809F-B65429D506EBQ33624341-236DC267-66A2-4262-B4A6-C7AB45651014Q34156711-64107769-E002-4335-BBB2-699072F2E81DQ34392016-1B3B0C6C-0452-4928-8BF6-6DA4F3C94F03Q34677275-2E9C2289-854E-436E-AB4D-D7950F8C9A72Q35126551-A340C877-C01A-44D2-98DF-958DA828B57CQ35349261-E65F1923-D82B-4B5E-B439-DB0DF5F622E5Q35553022-AC74E066-D2DF-4584-AC69-E0B6A34AF50BQ35600264-63E90B85-17FE-44F1-9189-63D3EDE34DE3Q35607174-2A805137-D223-4D68-A5F0-D407F99672F6Q36019061-D607B72A-B70C-441A-969D-1DB69D0CB6C0Q36028651-52B4FE99-65A9-4769-80C9-347A9C26891DQ36623685-D7147CDE-925E-4941-AECB-C295073549DFQ36628197-22CD9A89-926F-4F81-8D8D-FEE125F21A8AQ36956349-FCB0C680-6DA1-4C00-85A4-6D56C673D483Q36967376-13364778-285B-4992-B635-24CF6B9C0D81Q37118257-2746CE83-5981-4892-B6FF-689AA2F382EAQ37290665-B31E182D-A264-4B29-A400-F7CE3EC69B24Q37468752-9FC810B3-DAA7-4E79-B355-F73E19D8405FQ38366902-2B47595F-3A99-4AC0-93AD-0C190C1C8502Q40151836-4EE050D4-1F72-41A3-84EF-9767A5155367Q41233076-75BB1205-61D0-4219-BE4F-E59C8B686A60Q41234204-7AFCD998-9C4E-45D3-BA56-CB55AA53626AQ41997239-7D3299E4-B248-444F-8009-12C4A69C89CAQ42100340-FD5D6D64-1C5C-4206-91F3-6F9791081D98Q42799388-145EBD49-1D58-4C38-A092-434B6E26FD8BQ49539654-5EA59DCD-3D1B-44DD-B508-56030CA4CACEQ55091235-6477B630-BD33-4037-8FCC-3B948B881384
P2860
Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh-hant
name
Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon.
@en
Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon.
@nl
type
label
Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon.
@en
Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon.
@nl
prefLabel
Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon.
@en
Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon.
@nl
P1476
Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon
@en
P2093
P577
1988-07-01T00:00:00Z